.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Express Scripts
Argus Health
Fuji
Chubb
Merck
Teva
Healthtrust
Cantor Fitzgerald

Generated: June 24, 2017

DrugPatentWatch Database Preview

OPTICROM Drug Profile

« Back to Dashboard

Which patents cover Opticrom, and when can generic versions of Opticrom launch?

Opticrom is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in OPTICROM is cromolyn sodium. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.

Summary for Tradename: OPTICROM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list77
Patent Applications: see list4,557
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OPTICROM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OPTICROM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 19843,975,536► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 19843,419,578► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 19844,053,628► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 19843,777,033► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 19843,686,412► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Queensland Health
Daiichi Sankyo
Colorcon
AstraZeneca
Fish and Richardson
Healthtrust
Accenture
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot